According to the sources, The DCGI (The Drugs Controller General of India) granted permission to Mukesh Ambani-owned Reliance Life Sciences to conduct its COVID-19 vaccine trial on friday with certain conditions. The safety, tolerability and immunogenicity of the SARS-CoV-2 recombinant protein subunit vaccine in healthy
Morepen Laboratories has started production of the test batch of Russia’s Sputnik V COVID-19 vaccine at its facility in Himachal Pradesh, Russian Direct Investment Fund (RDIF) and the domestic drug firm said in a statement on Tuesday. The first batch will be shipped to Gamaleya
India’s drug regulator has refused to grant emergency-use authorisation to single-dose COVID-19 vaccine Sputnik-Light, while ruling out the need for the conduct of the phase-3 trial of the Russian vaccine in the country. According to the recommendations of the Subject Expert Committee (SEC) meeting held on
Dr Reddy’s Laboratories which has soft-launched Russia’s COVID-19 vaccine Sputnik V here has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi. Presently it being a limited pilot phase, registration on CoWIN is not open for
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
